Dr Paweł Wiśniewski has over 12 years of experience in development and implementation of biotechnology business strategies, which he has gained by holding top management positions in multiple companies within new technologies, biotech and healthcare sectors. He is also an author and co-author of numerous scientific papers, recognised at the international level.
Dr Wiśniewski is a founder and CEO of Instytut Analiz Genetycznych sp. z o.o. - INAGEN, a Poland-based company providing genetic profiling solutions to professional sports entities and individual athletes. He also holds a position of Vice-President of the Management Board of 4Cell Therapies S.A., a biotechnological company developing cell therapies for treatment of haematological and solid malignancies in Poland.
At the same time, Dr Wiśniewski provides advisory services to the investors and biotechnological companies world-wide and holds a position of Vice-Chairman of the Supervisory Board at Pure Biologics S.A., a publicly listed biotechnological company.
